You are about to leave the Clinical Value website now.
The integration of next-generation sequencing (NGS) comprehensive gene profiling (CGP) into clinical practice is playing an increasingly important role in oncology. Therefore, the HKU-HKSH Multi-disciplinary Molecular Tumour Board (MTB) was…
Read Article
These recommendations provide a critical guidance from NGS panel testing to final treatment decision based on MTB discussion.
Read Article
While precision oncology has shown great promise, there are still barriers to its implementation, such as data fragmentation, staff shortages and time, funding, and lack of standardization. The use of…
Read Article
Globally, cancer is the leading cause of death, accounting for nearly 1 in 6 deaths in 2020 with majority coming from Asia. Given today’s ageing population, and emerging factors like diet and environment, the burden of cancer is only projected to increase.
To tackle the rising cancer burden and increase the chances of survival, the integration of diagnostic testing and treatment is key. In the era of precision oncology, genomic profiling, clinical decision support solutions, and multidisciplinary partnership can enable early diagnosis and personalised treatment, presenting the opportunity to improve the lives of millions of people around the world.
This whitepaper shares recommendations on ensuring standardization and quality of NGS across the region, to realize the potential of NGS and establish more effective and market-appropriate…
READ MORE
Diagnostic technologies are used across the entire patient journey of multiple disease states, and provide the tools to prevent, detect, and monitor the required interventions. Despite…
READ MORE
In this article, Prof Peter Gibbs and Prof Svetlana Cherepanoff discuss the issues surrounding the clinical integration of NGS in Australia.
READ MORE
NGS and digital applications for oncology management can help improve early cancer detection and prevention, reducing human and economic costs of the cancer. In this article,…
READ MORE
In this article, Dr Amit Rauthan shares insights on the challenges and opportunities for greater NGS adoption in India.
READ MORE
In this article, Dr Lam Tai-Chung shares how his institution has had first-hand experience of landmark cases and outstanding treatment responses from using NGS in seemingly…
READ MORE
In this article, Dr David Tan discusses the potential of NGS in Singapore, where the adoption of this technology is only just beginning to take root.
READ MORE
In this article, Prof Jee Hyun Kim explains her clinical experiences of NGS, and how she sees it evolving within South Korea’s innovative healthcare ecosystem.
READ MORE
While precision oncology has shown great promise, there are still barriers to its implementation, such as data fragmentation, staff shortages and time, funding, and lack of…
READ MORE
This study proposes a unified framework to classify targets for precision cancer medicine based on clinical evidence of utility, to aid oncologists in prioritising potential targets…
READ MORE
The integration of next-generation sequencing (NGS) comprehensive gene profiling (CGP) into clinical practice is playing an increasingly important role in oncology. Therefore, the HKU-HKSH Multi-disciplinary Molecular…
READ MOREThis whitepaper shares recommendations on ensuring standardization and quality of NGS across the region, to realize the potential of NGS and establish more effective and market-appropriate…
READ MOREThese recommendations provide a critical guidance from NGS panel testing to final treatment decision based on MTB discussion.
READ MOREDiagnostic technologies are used across the entire patient journey of multiple disease states, and provide the tools to prevent, detect, and monitor the required interventions. Despite…
READ MORE
Expert talks and panels on genomic profiling, liquid biopsy, and novel gene management in cancer across Asia-Pacific and global contexts.
READ MORE
The field of clinical oncology continues to see drastic advancements with non-invasive techniques, such as liquid biopsy being adopted for diagnosing and monitoring cancers in place…
READ MORE
The growing amount of clinical data available for each patient, clinicians need to manage massive genomic information, histological analysis tools, and clinical trials and publications. They…
READ MORE
